Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 439

    APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

    APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

    supriya kashyap kashyap16 April 2017 10:20 AM IST
    A first-of-its-kind Indian biotechnology company, APAC Biotech, was granted with a commercial license by Indian FDA (CDSCO - Central Drugs Standard...
    Eli Lilly defeats Teva appeal over Alimta cancer drug

    Eli Lilly defeats Teva appeal over Alimta cancer drug

    supriya kashyap kashyap16 April 2017 10:14 AM IST
    A U.S. appeals court said Eli Lilly and Co may block Teva Pharmaceutical Industries Ltd from selling a generic equivalent of its top-selling lung...
    USFDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant

    USFDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant

    supriya kashyap kashyap15 April 2017 11:13 AM IST
    The U.S. Food and Drug Administration declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the...
    Dr Mohans Diabetes Specialties Centre receives Rs 66 Cr in Series A funding

    Dr Mohan's Diabetes Specialties Centre receives Rs 66 Cr in Series A funding

    savita thakur thakur15 April 2017 10:07 AM IST
    Diabetes care provider, Dr Mohan's Diabetes Specialties Centre, founded in 1991 has received 10.23 million dollars (about Rs 66 crore) in a Series A...
    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    supriya kashyap kashyap15 April 2017 9:40 AM IST
    Royal Philips, a global leader in health technology, announced it has received regulatory clearance (via De Novo classification) from the U.S. Food...
    Dr Reddys recalls 1,728 bottles of dementia drug from US

    Dr Reddy's recalls 1,728 bottles of dementia drug from US

    supriya kashyap kashyap15 April 2017 9:34 AM IST
    New Delhi : Drug firm Dr Reddy's Laboratories is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to...
    ASPA lobbies for mandatory authentication for medicines

    ASPA lobbies for mandatory authentication for medicines

    supriya kashyap kashyap14 April 2017 11:23 AM IST
    Kolkata : The Authentication Solution Providers Association (ASPA) emphasised the need for specific anti-counterfeit laws in the country to stem the...
    USFDA issues warning letter to Mylan for Nashik facility

    USFDA issues warning letter to Mylan for Nashik facility

    supriya kashyap kashyap14 April 2017 11:20 AM IST
    New Delhi : The US health regulator has issued a warning letter to drug firm Mylan for violations of good manufacturing norms, including data...
    Cipla arm completes acquisition of South Africa-based firm

    Cipla arm completes acquisition of South Africa-based firm

    supriya kashyap kashyap14 April 2017 11:19 AM IST
    New Delhi : Drug firm Cipla said it's subsidiary in South Africa has completed the acquisition of Anmarate (Pty) Ltd, South Africa, a deal estimated...
    Bristol-Myers to license two drugs to Biogen, Roche

    Bristol-Myers to license two drugs to Biogen, Roche

    supriya kashyap kashyap14 April 2017 9:20 AM IST
    Bristol-Myers Squibb Co said it would license two of its drugs to Biogen Inc and Roche Holding AG for an upfront fee of $470 million.Bristol will...
    Strand Life Sciences launches Liquid Biopsy test tool

    Strand Life Sciences launches Liquid Biopsy test tool

    supriya kashyap kashyap13 April 2017 12:54 PM IST
    Bengaluru : Developing a health product that can help with better detection of cancer, city-based Strand Life Sciences launched 'Strand LB' a Luquid...
    Chinese private hospital to buy largest EU eye clinic group

    Chinese private hospital to buy largest EU eye clinic group

    supriya kashyap kashyap13 April 2017 12:52 PM IST
    Beijing : China’s largest private ophthalmic medical chain Aier Eye Hospital has said it will buy Europe’s biggest eye clinic group for over USD 160...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok